Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Khiron Life Sciences Corp V.KHRN.H

Alternate Symbol(s):  V.KHRN.WT.H | KHRNF | KHRWF

Khiron Life Sciences Corp. is a Canada-based medical cannabis company with core operations in Latin America. The Company has its wholly owned medical health clinics and telemedicine platforms. The Company has two product lines: Medical Cannabis Products and Health Services. It sells branded medical cannabis products to patients with medical conditions. Under the Medical Cannabis Products line, the Company is focused on product sales in Latin America. The Company operates its own network of health centers (operating under the Zerenia brand) and Zerenia satellite clinics offering a suite of health, medical and surgical services, in alignment with both insurance company partners and private practice. Its subsidiaries include Khiron Life Sciences Corp. (Canada), Khiron Colombia S.A.S., Zerenia S.A.S., NettaGrowth International Inc., and others.


TSXV:KHRN.H - Post by User

Bullboard Posts
Post by KingTigeron Dec 01, 2018 11:56am
144 Views
Post# 29049410

Share this with the board

Share this with the board

 

Cresco Labs name change from Randsburg, CSE listing

 

2018-11-30 15:18 ET - Change Name

See New Listing (C-CL) Cresco Labs Inc

CSE bulletin 2018-1136

The subordinate voting shares of Cresco Labs Inc. have been approved for listing on the Canadian Securities Exchange.

Listing and disclosure documents will be available on the CSE website on the trading date. Cresco Labs, based in Chicago, is a grower, processor and retailer of premium cannabis with operations in six states (Illinois, Ohio, Pennsylvania, Nevada, California and Arizona) and approval pending for acquisitions in three more states (New York, Massachusetts and Maryland). The company focuses on entering markets with outsized demand potential, significant supply constraints and high barriers to entry. Its speed to market -- seven months from licence to market -- gives Cresco a competitive advantage as it replicates its model to expand its national footprint. Cresco's ability to execute is complemented by a brand strategy that is tailored to all major consumer segments: everyday cannabis, medicinally focused, connoisseur-grade and chef-inspired edibles by James Beard award-winning pastry chef Mindy Segal. Learn more about the company at the Cresco website.

 

Issuer:  Cresco Labs

Security type:  subordinate voting shares

Symbol:  CL

Number of securities issued and outstanding:  21,873,969

Number of securities reserved for issuance:  272,693,904

CSE sector:  life sciences

Cusip No.:  22587M 10 6

ISIN:  CA 22587M 10 6 8

Board lot:  100

Trading currency:  Canadian dollar

Trading date:  Dec. 3, 2018

Other exchanges:  not applicable

Fiscal year-end:  Dec. 31

Transfer agent:  Odyssey Trust Company

 

The exchange is accepting market-maker applications for CL.


Bullboard Posts